StockData
SAB Biotherapeutics, Inc. logo

SAB Biotherapeutics, Inc. (SABS) stock

SABSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$3.20+0.25 (+8.47%)

Close on Nov 18, 2026Market cap $291.16MP/E –Yield –

SAB Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

SAB Biotherapeutics's market cap was $259.66M on Nov 11, 2026, against $187.60M a year earlier. Over the last 5 years it ranged from $12.63M to $380.64M, with a median of $55.40M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$259.66M+46.2%
2025Dec 31, 2025$177.63M+407.3%
2024Dec 31, 2024$35.02M-44.8%
2023Dec 29, 2023$63.48M+41.7%
2022Dec 30, 2022$44.80M-1.3%
2021Dec 31, 2021$45.37M–

More SAB Biotherapeutics figures

See a number that looks wrong?